Overview of Aflavic
Aflavic is an oral pharmaceutical preparation whose identity is defined by its active component, Diosmin, and its classification as a specialized venoactive drug. The information presented here establishes the drug's nature and general purpose, strictly avoiding details on administration, specific treatments, or safety profiles.
| Property | Description |
|---|---|
| Active ingredient | Diosmin (INN) |
| Form | Oral Tablets (typically film-coated) |
| Pharmacological class | Venoactive Drug / Phlebotonic |
| General purpose | Supports vein tone and capillary integrity |
| Origin | Semi-synthetic (derived from Hesperidin) |
What Type of Medicine is Aflavic?
Aflavic is classified as a venoactive drug, an important category of medication intended to provide a functional benefit to the vascular system, specifically the veins and microcirculation. This designation means the preparation primarily acts as a phlebotonic and vasoprotective agent. The medication is administered in the form of oral tablets, which determines its systemic route of administration. Substances in this class are used to ease venous symptoms by improving vascular wall mechanics. This medicine helps ease discomfort by gently stimulating local circulation, a benefit clinically recognized for supporting long-term venous health.
Diosmin: Composition and Origin
The core active component in Aflavic is Diosmin, the International Nonproprietary Name (INN) for a compound chemically identified as a flavonoid glycoside. Diosmin, a type of bioflavonoid found in nature, is generally obtained for pharmaceutical use through a specialized semi-synthetic conversion process using the precursor compound, Hesperidin. To ensure superior biological effectiveness and absorption, the active ingredient is typically manufactured as a Micronized Purified Flavonoid Fraction (MPFF), a process that mechanically reduces particle size and increases the proportion of the drug that is efficiently absorbed into the body. This specific micronized formulation is a key differentiating factor, resulting in enhanced bioavailability compared to non-micronized Diosmin preparations.
General Purpose of a Venoactive Agent
The fundamental purpose of a vasoprotective agent is to maintain the functional integrity of the circulatory system's low-pressure side. The core mechanism involves combined venotonic and vasoprotective actions: increasing the tension of the vein walls and reinforcing the capillary lining. By supporting more effective blood flow and minimizing the abnormal leakage of fluid from small vessels into surrounding tissues, the medication generally helps to counteract impaired circulation. This functional support aims to provide relief from discomfort associated with venous issues, such as the typical feeling of heavy or tired legs after prolonged standing, specifically addressing feelings of heaviness and localized tissue swelling.
